Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year-old Alyssa was in remission, and she continues to do well several months later.

CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer, Cellular & Molecular Biology Letters

Alexa Miller on LinkedIn: I want to thank RiboClub for welcoming Revvity to their annual RNA…

Crispr Takes Its First Steps in Editing Genes to Fight Cancer - The New York Times

Health Archives, Page 101 of 641

Prime Editing Oversimplified. It has been 8 years since the first…, by Anush Mutyala

HOPA Bulletin

Vector engineering, strategies and targets in cancer gene therapy

Molecules December-1 2021 - Browse Articles

Health Archives, Page 76 of 327

CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer - Computational and Structural Biotechnology Journal

Gene editing helped crack a 100-year-old mystery about cancer - The Washington Post

Alexa Miller on LinkedIn: CRISPR-Cas9: From Bacterial Adaptive Immune Response To Editing and…

Health Archives - Page 101 of 100 - KTVZ